1 company and 4 research reports found for "Aeterna Zentaris"
- Aeterna Zentaris
Aeterna Zentaris is a specialty biopharmaceutical company developing novel treatments in oncology an...
No sector reports have been found.
Aeterna ZentarisPharmaceutical & healthcare | 01/10/2014
Edison Investment Research is terminating coverage on Aeterna Zentaris (AEZS). Please note you should no longer rely on any previous research or estim...
Aeterna ZentarisPharmaceutical & healthcare | 22/08/2014
Aeterna Zentaris is poised to transition to a commercial entity in 2015. Macrilen has an FDA PDUFA date of 5 November in the evaluation of adult growt...
Aeterna ZentarisPharmaceutical & healthcare | 10/06/2014
Aeterna Zentaris reported at the 2014 ASCO that 158 patients have been randomised as of 26 May 2014 in the zoptarelin doxorubicin in endometrial cance...